The "depressive" face of osteoporosis and the "osteoporotic" face of depression

被引:28
作者
Aloumanis, Kyriakos [1 ]
Mavroudis, Kostantinos [1 ,2 ]
机构
[1] Asklepieion Athens Gen Hosp, Private Med Off, Athens, Greece
[2] Asklepieion Athens Gen Hosp, Dept Endocrinol, Athens, Greece
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2013年 / 12卷 / 03期
关键词
Antidepressant medications; Causality; Depression; Falls; Fractures; Osteoporosis; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; DWELLING OLDER MEN; MAJOR DEPRESSION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; SEROTONIN; 5-HYDROXYTRYPTAMINE; VERTEBRAL FRACTURES; HIP FRACTURE; RISK-FACTOR;
D O I
10.1007/BF03401301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporosis and depression are two chronic diseases that affect large population groups with great impact on morbidity, mortality and quality of life. An association between osteoporosis and depression has been described in the literature. Definitely, limited data suggest that osteoporosis may enhance depressive symptoms, while far more studies have shown that depression adversely affects bone density and increases fracture risk. However, neither causation nor a firm pathophysiological connection has been established. Thus the correlation of these diseases is still under research. This review comments on a plausible causative relationship and underlying mechanisms that might elucidate the link between two very common diseases. We describe the possible impact of osteoporosis on moods and the (better established) effect of depression on bone health. We also describe the effect of medication and review hormonal and cellular signals that may explain this effect.
引用
收藏
页码:350 / 362
页数:13
相关论文
共 106 条
[1]  
Adami S, 2011, CLIN EXP RHEUMATOL, V29, P477
[2]   Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results fromthe European Forsteo Observational Study [J].
Aloumanis, K. ;
Karras, D. ;
Drossinos, V. ;
Korelis, E. ;
Polydorakis, A. .
JOURNAL OF OSTEOPOROSIS, 2011, 2011
[3]  
Amsterdam JD, 1998, PROG NEURO-PSYCHOPH, V22, P267
[4]  
Atteritano M, 2011, INTERN EMERG MED
[5]   Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women [J].
Aydin, Hasan ;
Mutlu, Nilgun ;
Akbas, Naz Berfu Gunel .
JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (10) :1316-1320
[6]   Depression, selective serotonin reuptake inhibitors and osteoporosis [J].
Bab I. ;
Yirmiya R. .
Current Osteoporosis Reports, 2010, 8 (4) :185-191
[7]   Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [J].
Baron, Roland ;
Hesse, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :311-325
[8]   The societal burden of osteoporosis [J].
Becker D.J. ;
Kilgore M.L. ;
Morrisey M.A. .
Current Rheumatology Reports, 2010, 12 (3) :186-191
[9]   Update in Serotonin and Bone [J].
Bliziotes, Michael .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (09) :4124-4132
[10]   Mortality following fractures in older women - The study of osteoporotic fractures [J].
Browner, WS ;
Pressman, AR ;
Nevitt, MC ;
Cummings, SR .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (14) :1521-1525